3 insiders bought €256k of shares over the last 90 days, the latest filed 09 Sept 2026.
Evolv Technologies Holdings, Inc. belongs to the Business Services sector. Filings by its managers are published through SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 50 filings came from 14 insiders.
The record shows 10 purchases on the open market worth €564k, made by 6 insiders, against 9 sales worth €4.2M by 2 insiders. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €847k, sold by Chitkara Anil and made public on 28 October 2025. Those buying include 5 senior executives and 1 chief executive.
Across the 5,812 companies tracked on its exchange, the median is 19 filings; at 50 filings, this issuer sits above that mark. Our records for Evolv Technologies Holdings, Inc. go back to 2021, with 20 purchases and 31 sales on the open market in total. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 145.9 m USD and net income at -33.1 m USD.
In all, 9 purchases were made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last insider purchase was made public on 9 September 2026, 38 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction.
Elsewhere in the same sector, our signals recently picked up insider purchases at Coursera, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
+3 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Evolv Technologies Holdings, Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$9.85.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 176 declarations
Evolv Technologies Holdings, Inc. is a United States-based company listed on the NASDAQ under the ticker EVLV. It operates in the AI-enabled physical security screening market, with headquarters in Waltham, Massachusetts, United States. The company sits at the intersection of security technology, software analytics, and crowd-flow automation, aiming to replace or complement traditional walk-through metal detection with faster, more seamless screening experiences for high-traffic environments. Its core positioning is not that of a conventional hardware vendor, but rather of a technology platform focused on safer and more efficient entry processes. ([ir.evolvtechnology.com](https://ir.evolvtechnology.com/?utm_source=openai))
Evolv’s roots lie in an entrepreneurial effort to rethink physical security screening using artificial intelligence and touchless detection. The company went public through a merger with NewHold Investment Corp., and its early communications emphasized a mission to modernize security while reducing friction for visitors, students, employees, and event attendees. That origin still defines the investment case today: Evolv is trying to transform a legacy security workflow by combining sensors, AI software, and data analytics into a differentiated screening system. ([ir.evolvtechnology.com](https://ir.evolvtechnology.com/news/press-releases/detail/33/evolv-technology-the-leader-in-ai-enabled-touchless-security-screening-to-become-publicly-traded-through-merger-with-newhold-investment-corp?utm_source=openai))
Commercially, Evolv focuses on venues and institutions where throughput matters: sports and entertainment venues, theme parks, schools, hospitals, public spaces, corporate campuses, and other locations with large visitor volumes. Its flagship product, Evolv Express, is presented as the company’s main weapons-detection and screening platform, while the broader portfolio also includes bag screening solutions and software tools that provide operational insights. The company markets its technology as a way to improve safety without sacrificing the visitor experience, a message that resonates particularly in environments where speed and customer experience are strategic priorities. ([ir.evolvtechnology.com](https://ir.evolvtechnology.com/?utm_source=openai))
From a competitive standpoint, Evolv occupies a niche but strategically attractive segment within security technology. Its value proposition is centered on high-throughput screening, AI-driven detection, and actionable analytics, which helps differentiate it from legacy security equipment providers. The company has repeatedly highlighted deployments at iconic venues and institutions, and it has cited a broad U.S. footprint across many states. This gives Evolv a brand advantage in a market where credibility, reference customers, and operational reliability are critical to adoption. ([ir.evolvtechnology.com](https://ir.evolvtechnology.com/?utm_source=openai))
Recent developments suggest continued commercialization and scale-up. In 2026, Evolv announced an Investor Day for June 9, 2026, and it reported that its flagship Express system had screened over four billion people worldwide. Recent earnings communications also pointed to continued revenue growth and ARR expansion, while management emphasized progress on profitability and liquidity. For investors, the company remains a growth-oriented security technology name on NASDAQ, with exposure to adoption cycles, contract wins, implementation timing, and regulatory scrutiny around AI-based screening solutions. ([ir.evolvtechnology.com](https://ir.evolvtechnology.com/news/press-releases/detail/264/evolv-technology-to-host-investor-day-on-june-9-2026?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 145.9 m USD | -33.1 m USD | -0.20 USD | 10-K |
| Dec 2024 | 103.9 m USD | -54.0 m USD | -0.34 USD | 10-K |
| Dec 2023 | 79.6 m USD | -108.0 m USD | -0.72 USD | 10-K |
| Dec 2022 | 52.7 m USD | -86.8 m USD | -0.60 USD | 10-K |
| Dec 2021 | 23.4 m USD | -10.9 m USD | -0.15 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.